NASDAQ:EUDA EUDA Health (EUDA) Stock Price, News & Analysis $12.00 -0.44 (-3.50%) Closing price 07/9/2026 03:57 PM EasternExtended Trading$11.60 -0.39 (-3.25%) As of 07/9/2026 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About EUDA Health Stock (NASDAQ:EUDA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EUDA Health alerts:Sign Up Key Stats Today's Range$12.43▼$12.4350-Day Range$11.81▼$18.7752-Week Range$5.26▼$86.00Volume753 shsAverage Volume3,849 shsMarket Capitalization$35.87 millionP/E RatioN/ADividend YieldN/APrice Target$55.00Consensus RatingHold Company Overview EUDA Health, Inc. (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health. EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation. These in-office treatment systems are complemented by a secure digital health platform that enables telehealth consultations, remote patient monitoring and real-time data insights for clinicians, aiming to improve patient adherence and clinical outcomes. The company distributes its devices and digital health services through a hybrid model of direct sales to healthcare practices and partnerships with established medical distributors. While its primary market is in the United States, EUDA Health has initiated market entry programs in select international regions and collaborates with clinical investigators to expand its evidence base. Led by a management team with deep experience in medical device innovation, digital therapeutics and women’s health, EUDA Health continues to pursue regulatory clearances, strategic collaborations and product enhancements. Through ongoing research and development efforts, the company aims to broaden its therapeutic offerings and further integrate its digital platform capabilities within the continuum of care. AI Generated. May Contain Errors. Read More EUDA Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreEUDA MarketRank™: EUDA Health scored higher than 48% of companies evaluated by MarketBeat, and ranked 471st out of 845 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingEUDA Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialEUDA Health has a consensus price target of $55.00, representing about 358.5% upside from its current price of $12.00.Amount of Analyst CoverageEUDA Health has only been the subject of 2 research reports in the past 90 days.Read more about EUDA Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Read more about EUDA Health's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.17% of the float of EUDA Health has been sold short.Short Interest Ratio / Days to CoverEUDA Health has a short interest ratio ("days to cover") of 1.28, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in EUDA Health has recently decreased by 37.33%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEUDA Health does not currently pay a dividend.Dividend GrowthEUDA Health does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EUDA Health insiders have not sold or bought any company stock.Percentage Held by Institutions4.35% of the stock of EUDA Health is held by institutions.Read more about EUDA Health's insider trading history. Receive EUDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EUDA Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EUDA Stock News HeadlinesNew health risks emerge as Europe’s drug market grows more complex, EU agency warnsJune 9, 2026 | msn.comEUDA Health Restores Nasdaq Compliance After Market Value ShortfallJune 1, 2026 | tipranks.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. | InvestorPlace (Ad)EUDA Health Holdings Limited Expands Helixé Product Line with Launch of Regenixé iPSC-derived Skin Stem Cell Secretome MaskJune 1, 2026 | quiverquant.comQEUDA Health Holdings Limited Regains Compliance with Nasdaq Listing RequirementsJune 1, 2026 | quiverquant.comQEUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome MaskJune 1, 2026 | globenewswire.comEUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value DeficiencyJune 1, 2026 | globenewswire.comEUDA Health Holdings Equity Warrant Exp 17th Nov 2027May 6, 2026 | cnbc.comSee More Headlines EUDA Stock Analysis - Frequently Asked Questions How have EUDA shares performed this year? EUDA Health's stock was trading at $46.20 at the beginning of the year. Since then, EUDA shares have decreased by 74.0% and is now trading at $11.9950. How were EUDA Health's earnings last quarter? EUDA Health Holdings Limited (NASDAQ:EUDA) posted its quarterly earnings results on Tuesday, May, 5th. The company reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($1.20) by $0.76. The business had revenue of $1.92 million for the quarter, compared to analyst estimates of $3.90 million. When did EUDA Health's stock split? Shares of EUDA Health reverse split on Monday, March 23rd 2026.A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, March 22nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of EUDA Health? Shares of EUDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EUDA Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that EUDA Health investors own include Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN), GT Biopharma (GTBP) and Company Calendar Last Earnings5/05/2026Today7/10/2026Next Earnings (Estimated)7/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 EUDA's financial health is in the Green zone, according to TradeSmith. EUDA has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:EUDA Previous SymbolNASDAQ:LAX CIK1847846 Webeuda.com Phone65-6788-0388Fax65-6788-0068Employees2Year Founded2022Price Target and Rating Average Price Target for EUDA Health$55.00 High Price Target$55.00 Low Price Target$55.00 Potential Upside/Downside+358.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.18 Sales & Book Value Annual Sales$6.82 million Price / Sales5.26 Cash FlowN/A Price / Cash FlowN/A Book Value($2.26) per share Price / Book-5.31Miscellaneous Outstanding Shares2,990,000Free FloatN/AMarket Cap$35.87 million OptionableNot Optionable Beta0.68 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:EUDA) was last updated on 7/10/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredIs the fix for AI's runaway power problem your golden ticket?The government just committed $200 billion to building computer chips on American soil - one of the largest te...Eagle Publishing | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMove your money (NOT into the next AI IPO)While headlines focus on AI IPOs, the world's largest investors are moving capital into one asset at the faste...Stansberry Research | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredExecutive order could send gold to 6,000 per ounceExecutive Order 14330 will allow Americans to hold precious metals inside 401(k)s for the first time ever - an...Cedar Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUDA Health Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EUDA Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
